Schrödinger is a New York-based life sciences and software company and strategic corporate investor relevant to biotechnology and pharmaceutical startups. Its physics-based computational platform supports molecular discovery across drug discovery and materials science, and its investment activity includes participation in later-stage U.S. venture rounds. Founder fit is strongest for companies in life sciences, computational chemistry, oncology, enterprise software for drug discovery, pharmaceuticals, and adjacent molecular or materials discovery markets.